Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?
Semicarbazide-sensitive amine oxidase (SSAO), occurs not only in vascular smooth muscle but also in other cell types (e.g. adipocytes, chondrocytes, odontoblasts), probably in the plasma membrane. Although certain aromatic biogenic amines (e.g. tryptamine, tyramine, ß-phenyl-ethylamine) may be endogenous substrates for SSAO in species such as the rat, the weak activity of SSAO in human tissues towards these amines makes this less likely in man. However SSAO in human and rat vascular homogenates readily converts the aliphatic biogenic amines methylamine and aminoacetone to formaldehyde and methylglyoxal, respectively. Also the xenobiotic aliphatic amine allylamine produces cardiovascular damage in experimental animals by a mechanism which involves its deamination by SSAO to acrolein. Further metabolism of these toxic aliphatic aldehydes may involve glutathione-dependent pathways. Thus, SSAO may be involved not only in the removal of physiologically-active endogenous/xenobiotic amines, but resulting metabolite (aldehyde/H2O2?) formation could also influence cellular function.
KeywordsAliphatic Amine Amine Oxidase SSAO Activity Amine Oxidase Activity Human Umbilical Artery
Unable to display preview. Download preview PDF.
- Blicharski JRD, Lyles GA (1990) Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells. J Neural Transm [Suppl] 32: 337–339.Google Scholar
- Blicharski JRD, Lyles GA (1991) D,L-buthionine sulphoximine, a glutathione-depleting agent, potentiates allylamine-induced cytotoxicity in rat aortic smooth muscle cell cultures. Br J Pharmacol 102: 184P.Google Scholar
- Fernandez de Arriba A, Balsa D, Tipton KF, Unzeta M (1990) Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in bovine eye. J Neural Transm [Suppl] 32: 327–330.Google Scholar
- Guffroy C, Boucher T, Strolin Benedetti M (1985) Further investigations of the metabolism of two trace amines, β-phenylethylamine and p-tyramine by rat aorta semicarbazide-sensitive amine oxidase. In: Boulton AA, Maitre L, Bieck PR, Riederer P (eds) Neuropharmacology of the trace amines. Humana Press, Clifton NJ, pp 39–50.CrossRefGoogle Scholar
- Lewinsohn R (1984) Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues. Brazilian J Med Biol Res 17: 223–256.Google Scholar
- Lizcano JM, Balsa D, Tipton KF, Unzeta M (1990) Amine oxidase activities in bovine lung. J Neural Transm [Suppl] 32: 341–344.Google Scholar
- Lyles GA (1984) The interaction of semicarbazide-sensitive amine oxidase with MAO inhibitors. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic Press, London, pp 547–556.Google Scholar
- Lyles GA, Bertie KH (1987) Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage. Pharmacol Toxicol 60 [Suppl] 1: 33.Google Scholar
- Lyles GA, Taneja DT (1987) Effects of amine oxidase inhibitors upon tryptamine metabolism and tryptamine-induced contractions of rat aorta. Br J Pharmacol 90: 16P.Google Scholar
- Norqvist A, Oreland L (1989) Localization of a semicarbazide-sensitive serotonin-oxidizing enzyme from porcine dental pulp. Biogenic Amines 6: 65–74.Google Scholar
- Strolin Benedetti M, Dosiert P (1985) Stereochemical aspects of MAO interactions: reversible and selective inhibitors of monoamine oxidase. TIPS 6: 246–251.Google Scholar
- Suzuki O, Matsumoto T (1984) Some properties of benzylamine oxidase in human aorta. Biogenic Amines 1: 249–257.Google Scholar